Vertex Pharmaceuticals Effect of Exchange Rate on Cash (Continuing Operations) remained flat by 0.0% to $22.73M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 313.4%, from -$10.65M to $22.73M. Over 2 years (FY 2023 to FY 2025), Effect of Exchange Rate on Cash (Continuing Operations) shows an upward trend with a 83.8% CAGR.
Large fluctuations indicate significant international exposure, where negative values reflect a strengthening functional currency against foreign holdings.
This represents the impact of foreign currency exchange rate fluctuations on the company's cash and cash equivalents hel...
Standard line item in the Statement of Cash Flows, typically labeled 'Effect of exchange rate changes on cash'.
is_cvx_fx_effect_on_cash_continuing_operations| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $26.90M | -$42.60M | $90.90M |
| YoY Change | — | -258.4% | +313.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.